Andreas Kerschbaumer
0000-0002-6685-8873
14 papers found
Refreshing results…
Definition of rheumatoid arthritis flare based on SDAI and CDAI
Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis
Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis
Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free?
EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Missing publications? Search for publications with a matching author name.